Temat: "PNEUMOCOCCAL vaccines" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016-2018-The ECAPS study.
Autorzy:: Hansen K; Section of Infectious Diseases, Department Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.; Section of Clinical Microbiology, Department Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Rünow E; Section of Infectious Diseases, Department Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.; Section of Clinical Microbiology, Department Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Torisson G; Section of Infectious Diseases, Department Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Theilacker C; Vaccines Global Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, United States.
Palmborg A; Pfizer Vaccines, Medical Development, Scientific and Clinical Affairs, Stockholm, Sweden.
Pan K; Vaccines Global Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, United States.
Jiang Q; Vaccines Global Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, United States.
Southern J; Vaccines Global Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, United States.
Beavon R; Vaccines Global Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, United States.
Gessner BD; Vaccines Global Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, United States.
Riesbeck K; Section of Clinical Microbiology, Department Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Ahl J; Section of Infectious Diseases, Department Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.; Section of Clinical Microbiology, Department Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.; Pokaż więcej
Źródło:: Frontiers in public health [Front Public Health] 2023 Feb 17; Vol. 11, pp. 1086648. Date of Electronic Publication: 2023 Feb 17 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Pneumococcal Vaccines*
Pneumonia*
Humans ; Adult ; Adolescent ; Aged ; Serogroup ; Sweden ; Hospitals, University

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: The role of a single-shot higher-valency pneumococcal vaccine in overcoming challenges regarding invasive pneumococcal disease in Hong Kong.
Autorzy:: Hui CKM; 813 Medical Centre, Hong Kong.
Hung IFN; Queen Mary Hospital, The University of Hong Kong, Hong Kong.; Gleneagles Hospital Hong Kong, Hong Kong.
Lam B; Hong Kong Sanatorium & Hospital, Hong Kong.
Lin AWC; HKSH Medical Group, Hong Kong.
So TMK; Virtus Medical Centre, Hong Kong.
Wong ATY; Princess Margaret Hospital, Hong Kong.
Wong MCS; The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.; Editor-in-Chief, Hong Kong Medical Journal.; Pokaż więcej
Źródło:: Hong Kong medical journal = Xianggang yi xue za zhi [Hong Kong Med J] 2023 Feb; Vol. 29 (1), pp. 11-14. Date of Electronic Publication: 2023 Feb 08.
Typ publikacji:: Editorial
MeSH Terms:: Pneumococcal Vaccines*
Pneumococcal Infections*/prevention & control
Humans ; Infant ; Hong Kong ; Streptococcus pneumoniae

Opinia redakcyjna

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: IgG antibody response to pneumococcal-conjugated vaccine (Prevenar®13) in children with immunodeficiency disorders.
Autorzy:: Garrido-Jareño M; Drug Discovery Unit, Health Research Institute Hospital La Fe, Valencia, Spain. .; Microbiology Department, University and Polytechnic Hospital La Fe, Avenida Fernando Abril Martorell, 106 Torre A 3ª Planta, 46026, Valencia, Spain. .; Valencian Institute of Pathology, Catholic University of Valencia, Valencia, Spain. .
Sahuquillo-Arce JM; Microbiology Department, University and Polytechnic Hospital La Fe, Avenida Fernando Abril Martorell, 106 Torre A 3ª Planta, 46026, Valencia, Spain.; Respiratory Infection Research Group, Health Research Institute Hospital La Fe, Valencia, Spain.
Rodríguez-Vega H; Paediatric Department, University and Polytechnic Hospital La Fe, Valencia, Spain.
Lloret-Sos C; Microbiology Department, University and Polytechnic Hospital La Fe, Avenida Fernando Abril Martorell, 106 Torre A 3ª Planta, 46026, Valencia, Spain.
Gil-Brusola A; Microbiology Department, University and Polytechnic Hospital La Fe, Avenida Fernando Abril Martorell, 106 Torre A 3ª Planta, 46026, Valencia, Spain.; Severe Infection Research Group, Health Research Institute Hospital La Fe, Valencia, Spain.
López-Hontangas JL; Microbiology Department, University and Polytechnic Hospital La Fe, Avenida Fernando Abril Martorell, 106 Torre A 3ª Planta, 46026, Valencia, Spain.; Severe Infection Research Group, Health Research Institute Hospital La Fe, Valencia, Spain.
Nuñez-Beltran M; Immunology Department, University and Polytechnic Hospital La Fe, Valencia, Spain.
Tortosa-Carreres J; Medical Analysis Department, University and Polytechnic Hospital La Fe, Valencia, Spain.
García-García JÁ; Valencian Institute of Pathology, Catholic University of Valencia, Valencia, Spain.
Cordón L; Hematology Research Group, Health Research Institute Hospital La Fe, Valencia, Spain.
Puchades-Carrasco L; Drug Discovery Unit, Health Research Institute Hospital La Fe, Valencia, Spain.
de Santivañes CC; Paediatric Department, University and Polytechnic Hospital La Fe, Valencia, Spain.
Pineda-Lucena A; Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.
Pemán-García J; Microbiology Department, University and Polytechnic Hospital La Fe, Avenida Fernando Abril Martorell, 106 Torre A 3ª Planta, 46026, Valencia, Spain.; Severe Infection Research Group, Health Research Institute Hospital La Fe, Valencia, Spain.; Pokaż więcej
Źródło:: Medical microbiology and immunology [Med Microbiol Immunol] 2023 Feb; Vol. 212 (1), pp. 93-102. Date of Electronic Publication: 2023 Jan 03.
Typ publikacji:: Journal Article
MeSH Terms:: Antibody Formation*
Pneumococcal Vaccines*
Child, Preschool ; Female ; Humans ; Male ; Antibodies, Bacterial ; Heptavalent Pneumococcal Conjugate Vaccine ; Immunoglobulin G ; Retrospective Studies ; Streptococcus pneumoniae ; Infant

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 4.

Tytuł:: A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION).
Autorzy:: Bili A; Merck & Co., Inc., Rahway, NJ, USA.
Dobson S; Parkside Clinical Research and Tribe Clinical Research, Greenville, SC, USA.
Quinones J; Clinical Research of Puerto Rico, Guayama, Puerto Rico.
Phongsamart W; Mahidol University, Bangkok, Thailand.
Oberdorfer P; Chiang Mai University, Chiang Mai, Thailand.
Kosalaraksa P; Khon Kaen University, Khon Kaen, Thailand.
Dagan R; The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Faculty of Health Sciences of the Ben-Gurion University of the Negev Beer-Sheva, Israel.
Richmond P; University of Western Australia School of Medicine, Perth, Australia.
Wilck M; Merck & Co., Inc., Rahway, NJ, USA.
Vallejos W; Merck & Co., Inc., Rahway, NJ, USA.
Nunn C; Merck & Co., Inc., Rahway, NJ, USA.
McFetridge R; Merck & Co., Inc., Rahway, NJ, USA.
Tamms G; Merck & Co., Inc., Rahway, NJ, USA.
Fu R; MSD, China.
Lupinacci R; Merck & Co., Inc., Rahway, NJ, USA.
Musey L; Merck & Co., Inc., Rahway, NJ, USA.
Banniettis N; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: .
Bickham K; Merck & Co., Inc., Rahway, NJ, USA.; Pokaż więcej
Corporate Authors:: V114-027 PNEU-DIRECTION study group
Źródło:: Vaccine [Vaccine] 2023 Jan 16; Vol. 41 (3), pp. 657-665. Date of Electronic Publication: 2022 Dec 13.
Typ publikacji:: Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Pneumococcal Vaccines*
Pneumococcal Infections*
Humans ; Infant ; Heptavalent Pneumococcal Conjugate Vaccine ; Vaccines, Conjugate ; Double-Blind Method ; Antibodies, Bacterial ; Immunoglobulin G

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 5.

Tytuł:: Increasing pneumococcal vaccine uptake in older adults: a scoping review of interventions in high-income countries.
Autorzy:: Kirubarajan A; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.; Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada.
Lynch M; Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada.
Nasreen S; Centre for Vaccine Preventable Diseases, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Gebretekle GB; Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Canada.
Fadel SA; Centre for Vaccine Preventable Diseases, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Crowcroft NS; Centre for Vaccine Preventable Diseases, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Allin S; Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada. .; Pokaż więcej
Źródło:: BMC geriatrics [BMC Geriatr] 2023 Jan 02; Vol. 23 (1), pp. 2. Date of Electronic Publication: 2023 Jan 02.
Typ publikacji:: Journal Article; Systematic Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Pneumococcal Vaccines*
Vaccination*
Aged ; Humans ; Developed Countries ; Electronic Health Records ; Immunization Programs/methods

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 6.

Tytuł:: Strengths and weaknesses of pneumococcal conjugate vaccines.
Autorzy:: Micoli F; GSK Vaccines Institute for Global Health, Siena, Italy. .
Romano MR; GSK Vaccines, Siena, Italy.
Carboni F; GSK Vaccines, Siena, Italy.
Adamo R; GSK Vaccines, Siena, Italy.
Berti F; GSK Vaccines, Siena, Italy.; Pokaż więcej
Źródło:: Glycoconjugate journal [Glycoconj J] 2023 Apr; Vol. 40 (2), pp. 135-148. Date of Electronic Publication: 2023 Jan 18.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Pneumococcal Vaccines*/therapeutic use
Pneumococcal Infections*/prevention & control
Pneumococcal Infections*/epidemiology
Humans ; Streptococcus pneumoniae ; Vaccination ; Vaccines, Conjugate/therapeutic use ; Antibodies, Bacterial

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 7.

Tytuł:: Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).
Autorzy:: Severance R; Synexus Clinical Research, Chandler, AZ, USA.
Schwartz H; Research Centers of America, Hollywood, FL, USA.
Dagan R; Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Connor L; Merck & Co., Inc., Kenilworth, NJ, USA.
Li J; Merck & Co., Inc., Kenilworth, NJ, USA.
Pedley A; Merck & Co., Inc., Kenilworth, NJ, USA.
Hartzel J; Merck & Co., Inc., Kenilworth, NJ, USA.
Sterling TM; Merck & Co., Inc., Kenilworth, NJ, USA.
Nolan KM; Merck & Co., Inc., Kenilworth, NJ, USA.
Tamms GM; Merck & Co., Inc., Kenilworth, NJ, USA.
Musey LK; Merck & Co., Inc., Kenilworth, NJ, USA.
Buchwald UK; Merck & Co., Inc., Kenilworth, NJ, USA.; Pokaż więcej
Źródło:: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1-14. Date of Electronic Publication: 2021 Nov 02.
Typ publikacji:: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms:: Immunogenicity, Vaccine*
Influenza Vaccines*/administration & dosage
Influenza Vaccines*/adverse effects
Pneumococcal Vaccines*/administration & dosage
Pneumococcal Vaccines*/adverse effects
Aged ; Antibodies, Bacterial ; Humans ; Influenza, Human/prevention & control ; Middle Aged ; Pneumococcal Infections/prevention & control ; Streptococcus pneumoniae/immunology ; Vaccines, Combined/adverse effects ; Vaccines, Conjugate/administration & dosage ; Vaccines, Conjugate/adverse effects

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 8.

Tytuł:: Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants".
Autorzy:: Gómez JA; Vaccine Department, GlaxoSmithKline, Buenos Aires, Argentina.
Pinto TJP; Vaccine Department, GlaxoSmithKline, Rio de Janeiro, Brazil.
Guevara JN; Vaccine Department, GlaxoSmithKline, Panama City, Panama.
Noronha TG; Institute of Technology for Immunobiologicals of Bio-Manguinhos, FIOCRUZ, Rio de Janeiro, Brazil.; Pokaż więcej
Źródło:: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1894898. Date of Electronic Publication: 2021 May 19.
Typ publikacji:: Letter; Comment
MeSH Terms:: Pneumococcal Vaccines*/immunology
Brazil/epidemiology ; Cost-Benefit Analysis ; Humans ; Infant ; Vaccines, Conjugate

Opinia redakcyjna

na półce

Szczegóły

Skocz do pozycji: 9.

Tytuł:: Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination-statistical analysis plan.
Autorzy:: Mackenzie GA; MRC Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia. .; Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK. .; Infection & Immunity Theme, Murdoch Children's Research Institute, Melbourne, Australia. .; Department of Paediatrics, University of Melbourne, Melbourne, Australia. .
Palmu AA; Finnish Institute for Health and Welfare, Helsinki, Finland.
Jokinen J; Finnish Institute for Health and Welfare, Helsinki, Finland.
Osei I; MRC Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia.; Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
Flasche S; Faculty of Epidemiology & Public Health, London School of Hygiene & Tropical Medicine, London, UK.
Greenwood B; Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
Mulholland K; Infection & Immunity Theme, Murdoch Children's Research Institute, Melbourne, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Australia.; Faculty of Epidemiology & Public Health, London School of Hygiene & Tropical Medicine, London, UK.
Nguyen C; Infection & Immunity Theme, Murdoch Children's Research Institute, Melbourne, Australia.; Pokaż więcej
Źródło:: Trials [Trials] 2022 Dec 28; Vol. 23 (1), pp. 1058. Date of Electronic Publication: 2022 Dec 28.
Typ publikacji:: Equivalence Trial; Journal Article; Randomized Controlled Trial
MeSH Terms:: Pneumococcal Infections*/prevention & control
Pneumococcal Infections*/epidemiology
Pneumococcal Vaccines*/adverse effects
Humans ; Infant ; Infant, Newborn ; Immunization Schedule ; Streptococcus pneumoniae ; Vaccination/adverse effects ; Vaccines, Conjugate/adverse effects ; Child, Preschool

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: A survey of systemic lupus erythematosus patients' attitudes toward influenza and pneumococcal vaccination in Southwest China.
Autorzy:: Chen Y; West China School of Nursing, Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Chen B; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Shen X; West China School of Nursing, Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Zhou A; West China School of Nursing, Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Liang Y; West China School of Nursing, Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Wang Y; West China School of Nursing, Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Chen H; West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.; Pokaż więcej
Źródło:: Frontiers in public health [Front Public Health] 2022 Dec 20; Vol. 10, pp. 1018899. Date of Electronic Publication: 2022 Dec 20 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Influenza Vaccines*
Influenza, Human*/prevention & control
Lupus Erythematosus, Systemic*
Immunocompromised Host*
Pneumococcal Vaccines*
Pneumococcal Infections*/prevention & control
Humans ; Surveys and Questionnaires ; Vaccination/adverse effects

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 11.

Tytuł:: Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1.
Autorzy:: Kim H; Department of Chemistry, University of Alabama at Birmingham, Birmingham, AL, United States.
Yu J; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Bai D; Department of Chemistry, University of Alabama at Birmingham, Birmingham, AL, United States.
Nahm MH; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.; World Health Organization (WHO) Pneumococcal Serology Reference Laboratory, University of Alabama at Birmingham, Birmingham, AL, United States.
Wang P; Department of Chemistry, University of Alabama at Birmingham, Birmingham, AL, United States.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2022 Dec 12; Vol. 13, pp. 1079047. Date of Electronic Publication: 2022 Dec 12 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Pneumococcal Vaccines*
Saponins*/pharmacology
Animals ; Mice ; Female ; Adjuvants, Immunologic/pharmacology ; Adjuvants, Pharmaceutic ; Immunoglobulin G

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 12.

Tytuł:: PneumoKITy: A fast, flexible, specific, and sensitive tool for Streptococcus pneumoniae serotype screening and mixed serotype detection from genome sequence data.
Autorzy:: Sheppard CL; Vaccine Preventable Bacteria Section, Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London NW9 5EQ, UK.; Present address: Genpax Ltd, 9 Pembridge Road, Notting Hill, London, W11 3JY, UK.
Manna S; Translational Microbiology Group, Murdoch Children's Research Institute, The University of Melbourne Department of Paediatrics at the Royal Children's Hospital, Parkville, Victoria, Australia.
Groves N; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London NW9 5EQ, UK.
Litt DJ; Vaccine Preventable Bacteria Section, Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London NW9 5EQ, UK.
Amin-Chowdhury Z; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, London NW9 5EQ, UK.
Bertran M; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, London NW9 5EQ, UK.
Ladhani S; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, London NW9 5EQ, UK.
Satzke C; Translational Microbiology Group, Murdoch Children's Research Institute, The University of Melbourne Department of Paediatrics at the Royal Children's Hospital, Parkville, Victoria, Australia.
Fry NK; Vaccine Preventable Bacteria Section, Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London NW9 5EQ, UK.; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, London NW9 5EQ, UK.; Pokaż więcej
Źródło:: Microbial genomics [Microb Genom] 2022 Dec; Vol. 8 (12).
Typ publikacji:: Journal Article
MeSH Terms:: Streptococcus pneumoniae*
Pneumococcal Vaccines*
Serogroup ; Serotyping/methods ; Whole Genome Sequencing

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 13.

Tytuł:: Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study.
Autorzy:: Nielsen KF; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark. .
Nielsen LB; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Lomholt FK; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Nørgaard SK; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Slotved HC; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Dalby T; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Fuursted K; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Jørgensen CS; Department of Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Valentiner-Branth P; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.; Pokaż więcej
Źródło:: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2022 Dec; Vol. 41 (12), pp. 1473-1477. Date of Electronic Publication: 2022 Oct 25.
Typ publikacji:: Journal Article
MeSH Terms:: Pneumococcal Vaccines*
Pneumococcal Infections*/epidemiology
Pneumococcal Infections*/prevention & control
Humans ; Cohort Studies ; Serogroup ; Denmark/epidemiology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 14.

Tytuł:: Multi-valent pneumococcal conjugate vaccine for global health: From problem to platform to production.
Autorzy:: Datta A; Bacterial Vaccine R&D, Inventprise, Inc., Redmond, WA, USA.
Kapre K; Bacterial Vaccine R&D, Inventprise, Inc., Redmond, WA, USA.; Process Automation & Support, Inventprise, Inc., Redmond, WA, USA.
Andi-Lolo I; Bacterial Vaccine R&D, Inventprise, Inc., Redmond, WA, USA.; Portfolio Management, Inventprise, Inc., Redmond, WA, USA.
Kapre S; Bacterial Vaccine R&D, Inventprise, Inc., Redmond, WA, USA.; Founder Chairman, Inventprise, Inc., Redmond, WA, USA.; Pokaż więcej
Źródło:: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (4), pp. 2117949. Date of Electronic Publication: 2022 Oct 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Pneumococcal Vaccines*
Pneumococcal Infections*/prevention & control
Child ; Humans ; United States ; Infant ; Vaccines, Conjugate ; Global Health ; Cost of Illness

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 15.

Tytuł:: Cost-utility analysis of the universal pneumococcal vaccination programme for older adults in Norway.
Autorzy:: Nymark LS; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
Dag Berild J; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
Lyngstad TM; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
Askeland Winje B; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
Frimann Vestrheim D; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
Aaberge I; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
Juvet LK; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
Wolff E; Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Solna, Sweden.; Pokaż więcej
Źródło:: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (6), pp. 2101333. Date of Electronic Publication: 2022 Aug 02.
Typ publikacji:: Journal Article
MeSH Terms:: Pneumococcal Vaccines*
Pneumococcal Infections*/prevention & control
Humans ; Aged ; Cost-Benefit Analysis ; Vaccines, Conjugate ; Immunization Programs ; Streptococcus pneumoniae ; Vaccination ; Quality-Adjusted Life Years

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 16.

Tytuł:: Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease.
Autorzy:: Sabharwal C; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
Sundaraiyer V; Biostatistics, Syneos Health, Somerset, NJ, USA.
Peng Y; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
Moyer L; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
Belanger TJ; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
Gessner BD; Vaccines Medical Development and Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Jodar L; Vaccines Medical Development and Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Jansen KU; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
Gruber WC; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
Scott DA; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
Watson W; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.; Pokaż więcej
Źródło:: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (6), pp. 2126253. Date of Electronic Publication: 2022 Nov 11.
Typ publikacji:: Clinical Trial; Journal Article
MeSH Terms:: Pneumococcal Infections*/prevention & control
Pneumococcal Vaccines*
Adolescent ; Adult ; Humans ; Middle Aged ; Young Adult ; Antibodies, Bacterial ; Immunogenicity, Vaccine ; Streptococcus pneumoniae ; Vaccines, Conjugate

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 17.

Tytuł:: Immunogenicity and protective efficacy of a prototype pneumococcal bioconjugate vaccine.
Autorzy:: Aceil J; Department of Biochemistry and Molecular Biology, University of Georgia, Athens GA 30602, USA; Center for Molecular Medicine, University of Georgia, Athens GA 30602, USA.
Paschall AV; Department of Biochemistry and Molecular Biology, University of Georgia, Athens GA 30602, USA; Center for Molecular Medicine, University of Georgia, Athens GA 30602, USA; Presently at: Department of Biochemistry, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
Knoot CJ; Omniose, St. Louis, MO 63110, USA.
Robinson LS; Omniose, St. Louis, MO 63110, USA.
Scott NE; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3010, Australia.
Feldman MF; Omniose, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Harding CM; Omniose, St. Louis, MO 63110, USA. Electronic address: .
Avci FY; Department of Biochemistry and Molecular Biology, University of Georgia, Athens GA 30602, USA; Center for Molecular Medicine, University of Georgia, Athens GA 30602, USA; Presently at: Department of Biochemistry, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: .; Pokaż więcej
Źródło:: Vaccine [Vaccine] 2022 Oct 06; Vol. 40 (42), pp. 6107-6113. Date of Electronic Publication: 2022 Sep 15.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Pneumococcal Infections*
Pneumococcal Vaccines*
Animals ; Antibodies, Bacterial ; Carrier Proteins ; Escherichia coli ; Mice ; Polysaccharides, Bacterial ; Vaccines, Conjugate

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 18.

Tytuł:: Parents' attitude towards pneumococcal vaccine: an online survey from Jordan.
Autorzy:: Al-Iede M; Division of Pediatric Pulmonology and Sleep Medicine, Department of Pediatrics, Jordan University Hospital, Amman, Jordan.; School of Medicine, The University of Jordan, Amman, Jordan.
Khanfar AN; School of Medicine, The University of Jordan, Amman, Jordan.
Alshrouf MA; School of Medicine, The University of Jordan, Amman, Jordan.
Azzam MI; School of Medicine, The University of Jordan, Amman, Jordan.
Haddad TA; School of Medicine, The University of Jordan, Amman, Jordan.
Khanfar ON; School of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Al-Tarawneh ZM; School of Medicine, Mutah University, Al-Karak, Jordan.
Aleidi SM; Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman, Jordan.; Pokaż więcej
Źródło:: The Journal of international medical research [J Int Med Res] 2022 Oct; Vol. 50 (10), pp. 3000605221128151.
Typ publikacji:: Journal Article
MeSH Terms:: Pneumococcal Infections*/prevention & control
Pneumococcal Vaccines*
Child ; Cross-Sectional Studies ; Humans ; Infant ; Jordan ; Parents ; Surveys and Questionnaires ; Vaccination ; Vaccines, Conjugate

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 19.

Tytuł:: Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials.
Autorzy:: Leach AJ; Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia. Electronic address: .
Wilson N; Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Arrowsmith B; Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Beissbarth J; Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Mulholland EK; Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia; Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Santosham M; Departments of International Health and Pediatrics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Center for American Indian Health, Baltimore, MD, USA.
Torzillo PJ; Royal Prince Alfred Hospital, University of Sydney, Sydney, NSW, Australia; Department of Medicine, University of Sydney, Sydney, NSW, Australia.
McIntyre P; University of Otago, Department of Women's and Children's Health, Dunedin, New Zealand.
Smith-Vaughan H; Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Chatfield MD; Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Lehmann D; Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.
Binks M; Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Chang AB; Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia; Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, QLD, Australia.
Carapetis J; Telethon Kids Institute, University of Western Australia, Perth, WA, Australia; Department of General Paediatrics, Perth Children's Hospital, Perth, WA, Australia.
Krause V; Centre for Disease Control, Northern Territory Health, Darwin, NT, Australia.
Andrews R; National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia.
Snelling T; School of Public Health, University of Sydney, Sydney, NSW, Australia.
Skull SA; Telethon Kids Institute, University of Western Australia, Perth, WA, Australia; Department of General Paediatrics, Perth Children's Hospital, Perth, WA, Australia.
Licciardi PV; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia; Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Oguoma VM; Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia; Poche Centre for Indigenous Health, University of Queensland, Brisbane, QLD, Australia.
Morris PS; Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia; Royal Darwin Hospital, Paediatrics Department, Darwin, NT, Australia.; Pokaż więcej
Źródło:: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Sep; Vol. 22 (9), pp. 1374-1387. Date of Electronic Publication: 2022 Jun 27.
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Hearing Loss*/immunology
Immunization, Secondary*
Indigenous Peoples*
Nasopharynx*/immunology
Nasopharynx*/microbiology
Otitis Media*/immunology
Pneumococcal Vaccines*/administration & dosage
Pneumococcal Vaccines*/immunology
Vaccines, Conjugate*/administration & dosage
Vaccines, Conjugate*/immunology
Antibodies, Bacterial/immunology ; Australia ; Haemophilus influenzae/immunology ; Humans ; Immunoglobulin G/immunology ; Infant ; Infant, Newborn ; Pneumococcal Infections/immunology ; Pneumococcal Infections/prevention & control ; Respiratory Tract Infections ; Streptococcus pneumoniae/immunology ; Time Factors

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 20.

Tytuł:: Development of a novel flow cytometry method for detecting pneumococcal-specific B cells.
Autorzy:: Tzovara I; Department of Infectious Diseases - Immunobiology and Vaccinology Research Lab, 'Aghia Sophia' Children's Hospital, 1st Department of Pediatrics - National and Kapodistrian University of Athens, Athens, Greece.
Papadatou I; Department of Infectious Diseases - Immunobiology and Vaccinology Research Lab, 'Aghia Sophia' Children's Hospital, 1st Department of Pediatrics - National and Kapodistrian University of Athens, Athens, Greece.
Tzanoudaki M; Department of Immunology and Histocompatibility, Specific Reference Centre for Primary Immunodeficiencies-Paediatric Immunology, 'Aghia Sophia' Children's Hospital, Athens, Greece.
Spoulou V; Department of Infectious Diseases - Immunobiology and Vaccinology Research Lab, 'Aghia Sophia' Children's Hospital, 1st Department of Pediatrics - National and Kapodistrian University of Athens, Athens, Greece.; Pokaż więcej
Źródło:: Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2022 Jul; Vol. 101 (7), pp. 588-596. Date of Electronic Publication: 2022 May 24.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibodies, Bacterial*
Pneumococcal Vaccines*/metabolism
B-Lymphocytes ; Flow Cytometry ; Streptococcus pneumoniae

Czasopismo naukowe

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""PNEUMOCOCCAL vaccines"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Starter badań:

Pneumococcal vaccine.